$DYAI
DYADIC INTERNATIONAL INC Stock $dyai

$dyai Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000121380920000018 Filed on March 30, 2020

Income Statement

Concept	2020 Q1	2019 Q4	2019
Revenue	$315.4K	$430.0K	$1.681M
YoY Change	-21.65%	-37.68%	29.77%
Cost Of Revenue	$278.2K	$420.0K	$1.460M
YoY Change	-15.16%	-17.65%	42.09%
Gross Profit	$37.19K	$10.00K	$221.4K
YoY Change	-50.16%	-94.44%	-17.45%
Gross Profit Margin	11.79%	2.33%	13.17%
Selling, General & Admin	$1.650M	$1.160M	$5.520M
YoY Change	15.38%	-9.38%	22.12%
% of Gross Profit	4436.68%	11600.0%	2493.51%
Research & Development	$755.5K	$780.0K	$3.088M
YoY Change	9.11%	21.88%	46.91%
% of Gross Profit	2031.33%	7800.0%	1394.74%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$755.5K	$1.950M	$3.088M
YoY Change	9.11%	1.56%	46.91%
Operating Profit	-$2.383M	-$1.940M	-$9.283M
YoY Change	-2.41%	11.49%	22.26%
Interest Expense	$168.4K	$210.0K	$984.9K
YoY Change	-36.93%	-8.7%	10.11%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.210M	-$1.730M	-$8.275M
YoY Change	1.84%	13.82%	24.94%
Income Tax	$0.00	$10.00K	$10.31K
% Of Pretax Income
Net Earnings	-$2.214M	-$1.740M	-$8.308M
YoY Change	1.79%	241.18%	45.96%
Net Earnings / Revenue	-702.07%	-404.65%	-494.21%
Basic Earnings Per Share
Diluted Earnings Per Share	-$80.51K	-$63.76K	-$307.8K
COMMON SHARES
Basic Shares Outstanding	27.36M shares	27.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.28M	$34.22M	$34.22M
YoY Change	-21.31%	-16.94%	-16.94%
Cash & Equivalents	$4.697M	$4.824M	$4.820M
Short-Term Investments	$26.59M	$29.40M	$29.40M
Other Short-Term Assets	$290.0K	$100.0K	$100.0K
YoY Change	0.0%	-76.74%	-76.74%
Inventory
Prepaid Expenses
Receivables	$518.6K	$558.5K	$560.0K
Other Receivables	$730.0K	$750.0K	$750.0K
Total Short-Term Assets	$32.82M	$35.64M	$35.64M
YoY Change	-20.55%	-16.63%	-16.63%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.520M	$1.510M	$1.510M
YoY Change
Other Assets	$50.49K	$51.31K	$50.00K
YoY Change	-0.91%	-1.58%	0.0%
Total Long-Term Assets	$2.569M	$1.813M	$1.810M
YoY Change	365.7%	228.04%	229.09%
TOTAL ASSETS
Total Short-Term Assets	$32.82M	$35.64M	$35.64M
Total Long-Term Assets	$2.569M	$1.813M	$1.810M
Total Assets	$35.39M	$37.45M	$37.45M
YoY Change	-15.46%	-13.51%	-13.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$653.4K	$943.4K
YoY Change	-31.08%	205.24%
Accrued Expenses	$240.0K	$566.0K	$570.0K
YoY Change	-20.78%	41.65%	42.5%
Deferred Revenue	$242.4K	$78.64K
YoY Change	953.0%	-44.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.136M	$1.588M	$1.590M
YoY Change	-10.85%	86.91%	87.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.136M	$1.588M	$1.590M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.140M	$1.590M	$1.590M
YoY Change	-10.24%	87.06%	87.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.57M	-$41.35M
YoY Change	23.7%	25.14%
Common Stock	$39.71K	$39.61K
YoY Change	1.91%	1.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$18.90M	$18.93M
YoY Change	0.0%	0.16%
Treasury Stock Shares
Shareholders Equity	$34.25M	$35.86M	$35.86M
YoY Change
Total Liabilities & Shareholders Equity	$35.39M	$37.45M	$37.45M
YoY Change	-15.46%	-13.51%	-13.51%

Cashflow Statement

Concept	2020 Q1	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	-$2.214M	-$1.740M	-$8.308M
YoY Change	1.79%	241.18%	45.96%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.996M	-$1.400M	-$5.783M
YoY Change	41.63%	13.82%	31.21%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.700M	$1.340M	$7.710M
YoY Change	-43.52%	-29.84%	131.53%
Cash From Investing Activities	$1.698M	$1.340M	$7.707M
YoY Change	-43.53%	-29.84%	131.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$175.0K	220.0K	$550.2K
YoY Change			-123.93%
NET CHANGE
Cash From Operating Activities	-$1.996M	-1.400M	-$5.783M
Cash From Investing Activities	$1.698M	1.340M	$7.707M
Cash From Financing Activities	$175.0K	220.0K	$550.2K
Net Change In Cash	-$126.7K	160.0K	$2.437M
YoY Change	-107.97%	-76.47%	-171.68%
FREE CASH FLOW
Cash From Operating Activities	-$1.996M	-$1.400M	-$5.783M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001213809
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	329711	USD
CY2018Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	294240	USD
CY2018Q4	us-gaap	Assets Assets	43300807	USD
CY2017Q2	dyai	Collaborative Arrangement Duration Of Agreement CollaborativeArrangementDurationOfAgreement	P2Y
CY2016Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2017Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	000-55264
CY2019	dei	Entity Registrant Name EntityRegistrantName	DYADIC INTERNATIONAL, INC.
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-0486747
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	140 Intracoastal Pointe Drive
CY2019	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 404
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	Jupiter
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33477
CY2019	dei	City Area Code CityAreaCode	561
CY2019	dei	Local Phone Number LocalPhoneNumber	743-8333
CY2019	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2019	dei	Trading Symbol TradingSymbol	DYAI
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	172001	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	42748052	USD
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	169700000	USD
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27359157	shares
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4823544	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2386314	USD
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	29399146	USD
CY2018Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	38816441	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	35639238	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	558530	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	943378	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	318744	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	250308	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	506866	USD
CY2019Q4	dyai	Prepaid Researchand Developmentin Process Current PrepaidResearchandDevelopmentinProcessCurrent	0	USD
CY2018Q4	dyai	Prepaid Researchand Developmentin Process Current PrepaidResearchandDevelopmentinProcessCurrent	253446	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	277999	USD
CY2019Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	1511636	USD
CY2018Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	0	USD
CY2019Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	250308	USD
CY2018Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	500616	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51314	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	52139	USD
CY2019Q4	us-gaap	Assets Assets	37452496	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	868720	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	849638	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	309060	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	566003	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	399576	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	78644	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	141002	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1588025	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39612659	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38966988	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27359157	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26713486	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	39613	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	38967	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96105851	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	94385230	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37452496	USD
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2019Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18929915	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41351078	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33043113	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	35864471	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	42451169	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43300807	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1681076	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1295451	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1459701	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1027278	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3087597	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2101628	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-7592445	USD
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-37516	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-21622	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2437230	USD
CY2018	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	1215536	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5519922	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4522676	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-27725	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-20778	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	10963665	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	8887896	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-9282589	USD
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	984930	USD
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	894532	USD
CY2019	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-8297659	USD
CY2018	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-6697913	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10306	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1006157	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-8307965	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-5691756	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1171079	USD
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27003695	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27673300	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	49975264	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	467203	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4500	USD
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2304042	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-5691756	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	42451169	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	550188	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-8307965	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	35864471	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-8307965	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-5691756	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1171079	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	467203	USD
CY2019	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	198208	USD
CY2018	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	676644	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-27725	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-20778	USD
CY2019	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	35471	USD
CY2018	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-195601	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	252772	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	59984	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-506866	USD
CY2018	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1007482	USD
CY2019	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	-253446	USD
CY2018	dyai	Increase Decreasein Prepaid Researchand Development IncreaseDecreaseinPrepaidResearchandDevelopment	-913013	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	105707	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17395	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	657658	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-195755	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	166399	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	251617	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-62358	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	141002	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-100675	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5782892	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4407189	USD
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	47615550	USD
CY2018	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	49734681	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	55323000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	53063000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7707450	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3328319	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2304042	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	550188	USD
CY2019Q4	dyai	Number Of Research Organization Performing Service Under Contract NumberOfResearchOrganizationPerformingServiceUnderContract	2	segment
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4500	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	550188	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2299542	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3400034	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2386314	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5786348	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4823544	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2386314	USD
CY2019	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	506866	USD
CY2018	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	0	USD
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:18pt;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates </span></div><div style="text-indent:36pt;text-align:justify;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.</span></div>
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	ConcentrationsThe Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, and investment securities. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts.
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	558530	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	318744	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	173890	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	91725	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	101221	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	77249	USD
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	2888	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3027	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	277999	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	172001	USD
CY2019Q4	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	69795	USD
CY2019Q4	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	766001	USD
CY2018Q4	dyai	Research And Development In Process Current ResearchAndDevelopmentInProcessCurrent	240064	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	26994	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2019Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	150383	USD
CY2018Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	68996	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	943378	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	309060	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	474388	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	268287	USD
CY2018Q4	dyai	Accrued Researchand Developmentin Process Current AccruedResearchandDevelopmentinProcessCurrent	49666	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	21820	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	81623	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	566003	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	399576	USD
CY2019	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	2578507	USD
CY2018	dyai	Research And Development Expense Outside Contracted Services ResearchAndDevelopmentExpenseOutsideContractedServices	1637953	USD
CY2019	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	868720	USD
CY2018	dyai	Research And Development Expense Contracted Services Related Party ResearchAndDevelopmentExpenseContractedServicesRelatedParty	1215536	USD
CY2019	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	423898	USD
CY2018	dyai	Research And Development Expense Personnel Related Costs ResearchAndDevelopmentExpensePersonnelRelatedCosts	376312	USD
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1100000	USD
CY2019Q4	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	35734326	USD
CY2019	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	85192	USD
CY2018	dyai	Research And Development Expense Facilities Overheadand Other ResearchAndDevelopmentExpenseFacilitiesOverheadandOther	87363	USD
CY2019	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	3956317	USD
CY2018	dyai	Research And Development Expense Including Related Party ResearchAndDevelopmentExpenseIncludingRelatedParty	3317164	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	17991	USD
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3860390	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3552890	shares
CY2019Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4823544	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4823544	USD
CY2019Q4	us-gaap	Investments And Cash InvestmentsAndCash	35738787	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	22452	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2386314	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2386314	USD
CY2018Q4	us-gaap	Investments And Cash InvestmentsAndCash	41117434	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	85321	USD
CY2018Q4	dyai	Investmentsand Cash Amortized Cost InvestmentsandCashAmortizedCost	41202755	USD
CY2017Q2	dyai	Collaborative Arrangement Paymentfor Researchand Development Agreement CollaborativeArrangementPaymentforResearchandDevelopmentAgreement	1000000	EUR
CY2019Q4	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	0	USD
CY2018Q4	dyai	Prepaid Researchand Development PrepaidResearchandDevelopment	300000	USD
CY2019	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	900000	USD
CY2018	dyai	Researchand Development Expense Related Party ResearchandDevelopmentExpenseRelatedParty	1200000	USD
CY2019	dyai	Tax Cutsand Jobs Act Change In Alternative Minimum Tax Income Tax Benefit TaxCutsandJobsActChangeInAlternativeMinimumTaxIncomeTaxBenefit	1001233	USD
CY2019	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	500000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8274712	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6622695	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-22947	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-75218	USD
CY2019	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-8297659	USD
CY2018	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-6697913	USD
CY2019	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2018	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-1001233	USD
CY2019	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2018	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2019	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2018	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2019	dyai	Income Tax Expense Benefit Including True Up Adjustment IncomeTaxExpenseBenefitIncludingTrueUpAdjustment	0	USD
CY2018	dyai	Income Tax Expense Benefit Including True Up Adjustment IncomeTaxExpenseBenefitIncludingTrueUpAdjustment	-1001233	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0461
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0425
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0649
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0044
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3099
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1025
CY2019	dyai	Effective Income Tax Rate Reconciliation True Up Adjustment Percent EffectiveIncomeTaxRateReconciliationTrueUpAdjustmentPercent	-0.0018
CY2018	dyai	Effective Income Tax Rate Reconciliation True Up Adjustment Percent EffectiveIncomeTaxRateReconciliationTrueUpAdjustmentPercent	0.0017
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0007
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0028
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0100
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2019	dyai	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Percent EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxPercent	0
CY2018	dyai	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Percent EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxPercent	-0.0006
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1495
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4400	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M9D
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9712729	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	275000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	242700	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5214200	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2668000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1656500	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1656500	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	11200	USD
CY2019Q4	dyai	Deferred Tax Asset Liability Gross DeferredTaxAssetLiabilityGross	7150100	USD
CY2018Q4	dyai	Deferred Tax Asset Liability Gross DeferredTaxAssetLiabilityGross	4578400	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7150100	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4578400	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	1103632	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19700000	USD
CY2018Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9100000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	2762175	USD
CY2019Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	496268	USD
CY2019Q4	us-gaap	Purchase Obligation PurchaseObligation	4362075	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860390	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3552890	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2712390	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.62
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M2D
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	69090	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1120500	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.44
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	30000	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.15
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	250000	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.69
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3552890	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.57
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y21D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1149461	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1089000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.26
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	781500	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.60
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860390	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.76
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M8D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	13287932	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2747073	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.65
CY2017Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	7863980	shares
CY2019Q2	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Boardof Directors SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofBoardofDirectors	3	board_of_director
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	781500	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.60
CY2019	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Net SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodNet	440000	shares
CY2019	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStock	304171	shares
CY2019	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Forfeited SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodForfeited	135829	shares
CY2019	dyai	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Cash SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCash	341500	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.69
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.41
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2925662	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	39360	USD
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	222330	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	162786	USD
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M29D
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M20D
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1171079	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	467203	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	645671	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	30000	shares
CY2019	dyai	Share Based Compensation Arrangements By Share Based Payment Award Options Issued In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice	1.60
CY2018	dyai	Share Based Compensation Arrangements By Share Based Payment Award Options Issued In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice	0.15
CY2016Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	USD
CY2017Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	USD
CY2016Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2136752	shares
CY2016Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.35
CY2016Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2884615	USD
CY2017Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2363590	shares
CY2017Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.54
CY2017Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3639929	USD
CY2016Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	15000000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	381607	shares
CY2017Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	5000000	USD
CY2017Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.58
CY2017Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12448283	USD
CY2017Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2551717	USD
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.41
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	537661	USD
CY2017Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4462339	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1644325	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.40
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2304042	USD
CY2018Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2158297	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	14390254	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	1.52
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	21814530	USD
CY2019Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12253502	shares
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	18900000	USD

Files In Submission

Name	View Source	Status
0001213809-20-000018-index-headers.html	Edgar Link	pending
0001213809-20-000018-index.html	Edgar Link	pending
0001213809-20-000018.txt	Edgar Link	pending
0001213809-20-000018-xbrl.zip	Edgar Link	pending
dyai-20191231.htm	Edgar Link	pending
dyai-20191231.xsd	Edgar Link	pending
dyai-20191231_cal.xml	Edgar Link	unprocessable
dyai-20191231_def.xml	Edgar Link	unprocessable
dyai-20191231_g1.jpg	Edgar Link	pending
dyai-20191231_g2.jpg	Edgar Link	pending
dyai-20191231_g3.jpg	Edgar Link	pending
dyai-20191231_htm.xml	Edgar Link	completed
dyai-20191231_lab.xml	Edgar Link	unprocessable
dyai-20191231_pre.xml	Edgar Link	unprocessable
exhibit1011jupiterlease2.htm	Edgar Link	pending
exhibit1011jupiterlease2001.jpg	Edgar Link	pending
exhibit311cert-mark10x.htm	Edgar Link	pending
exhibit312cert-ping10x.htm	Edgar Link	pending
exhibit321sect1350cert.htm	Edgar Link	pending
exhibit322sect1350cert.htm	Edgar Link	pending
exhibit42descriptionof.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYAI
DYADIC INTERNATIONAL INC Stock $dyai

2020 Q1 Form 10-K Financial Statement

#000121380920000018 Filed on March 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI DYADIC INTERNATIONAL INC Stock $dyai

2020 Q1 Form 10-K Financial Statement

#000121380920000018 Filed on March 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYAI
DYADIC INTERNATIONAL INC Stock $dyai